Ownership and insider activity for Baird Medical Investment Holdings Limited (BDMD): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions.
Price
| Price | $1.06 |
| Market Cap | $45M |
| Exchange | NASDAQ |
| Country | CN |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-03-18 | ExcelFin SPAC LLC | |||
| 2026-03-18 | ExcelFin SPAC LLC | |||
| 2026-03-18 | ExcelFin SPAC LLC | |||
| 2026-04-21 | Xu Lijian | |||
| 2026-04-21 | Qiu Quan | |||
| 2026-04-21 | Lu Rongjian | |||
| 2026-03-18 | Bilciu-Wolfson Gabrielle | |||
| 2026-04-15 | Li Jie Clara | |||
| 2026-03-18 | Ragan Joseph Douglas III | |||
| 2026-03-31 | Hou Wei |
Balance Sheet (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $220454 | $1.1M | $3.0M | $1.7M | $1.5M | $3.0M | $178321 |
| Short-term Investments | $36622 | $65106 | $407502 | $197000 | $120485 | 0 | 0 |
| Receivables | $4.6M | $8.2M | $12.4M | $24.8M | $31.5M | $46.6M | $42.5M |
| Inventory | $709474 | $810073 | $3.1M | $1.3M | $1.1M | $1.3M | $1.1M |
| Total Current Assets | $8.7M | $13.1M | $22.4M | $33.8M | $40.1M | $61.4M | $55.0M |
| Property, Plant & Equipment | $1.7M | $2.8M | $3.3M | $2.7M | $7.0M | $7.6M | $6.5M |
| Goodwill | $60606 | $64646 | $66173 | $61140 | $59375 | $57772 | $60303 |
| Intangible Assets | $143618 | $107233 | $62768 | $49481 | $25479 | $16527 | $8626 |
| Total Assets | $11.8M | $17.0M | $26.1M | $42.6M | $56.7M | $78.0M | $69.7M |
| Accounts Payable | $100245 | $61123 | $340212 | $215863 | $550188 | $1.3M | $1.8M |
| Short-term Debt | $28.1M | $2.4M | $2.0M | $6.2M | $8.2M | $17.0M | $13.1M |
| Total Current Liabilities | $33.6M | $9.3M | $9.8M | $16.0M | $19.0M | $34.6M | $32.4M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | $3.4M | $6.1M |
| Total Liabilities | $34.3M | $10.3M | $10.3M | $16.8M | $21.0M | $38.2M | $38.5M |
| Retained Earnings | -$15.7M | -$9.6M | -$7.1M | $4.0M | $14.4M | $26.8M | -$515415 |
| Total Equity | -$21.9M | $7.2M | $5.2M | $25.9M | $35.8M | $39.7M | $31.4M |
| Total Debt | $28.9M | $4.1M | $2.9M | $7.4M | $9.9M | $20.9M | $19.3M |
| Net Debt | $28.7M | $2.9M | -$505103 | $5.5M | $8.3M | $17.9M | $19.1M |
| Working Capital | -$24.9M | $3.8M | $12.6M | $17.7M | $21.1M | $26.8M | $22.6M |
Financial Health
| Debt / Equity | 0.41 |
| Current Ratio | 1.29 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 0.08 |
Profitability
| Return on Equity | -48.29% |
| Return on Invested Capital | -26.96% |
| Return on Assets | -21.63% |
| Gross Margin | 85.63% |
| Operating Margin | -58.52% |
| Net Margin | -65.20% |
Related companies: BDSX · BEAT · CTSO · ECOR · FGEN · ICCM · NMTC
Explore sector: Healthcare · Medical - Devices
More sections of BDMD: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks